InvestorsHub Logo

Chess Master

08/11/20 2:15 PM

#104505 RE: Venture_Cap #104475

Very frustrated with your analysis. THEY MET THE PRIMARY ENDPOINT! What is your issue?

Primary endpoint shows early clinical improvement in symptom score at Day 3 in patients receiving leronlimab

Clinical improvement assessed by change in total clinical symptom score:
from the press release